MetaCap

Celularity (CELU) News

NASDAQ: CELUHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.463-0.0049 (-1.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CELU news summary

We found 2 recent headlines mentioning Celularity (CELU): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, CELU is down 1.05% at $0.463. The most recent story, "Celularity Inc. Announces Exclusive Peptide API Manufacturing Collaboration with Vesalius Longevity Labs on October 29, 2026", was published by Nasdaq on Oct 29, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Celularity headlines

Stocks mentioned alongside CELU

Compare CELU